Siemens Healthineers (NYSE:SI) said today it is investing approximately $300 million over 4 years into its Walpole, Mass.-based laboratory diagnostics manufacturing and R&D facility.
The Walpole facility currently employs 700 employees and is the main manufacturing center for the company’s Advia Centaur assays and for molecular and blood gas testing consumables, Siemens said.
“The expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing footprint in the United States, the largest healthcare market in the world. The laboratory instruments and reagents developed and manufactured at the Siemens Healthineers Walpole facility impact patients and healthcare providers across the globe,” Siemens Healthineers CEO Bernd Montag said in a press release.
The company said it plans to expand its existing 500,000 sq. ft. complex with extra manufacturing, warehouse, office and lab space, with renovations starting in the coming weeks.
“With a 37-year history of manufacturing products in Walpole, we saw an opportunity to leverage the local talent in the community to further our growth and expansion plans,” Siemens Healthineers lab diagnostics prez Franz Walt said in prepared remarks.
Siemens said it plans to add at least 400 positions, while anticipating as many as 700 new positions at the facility, bringing total employment to between 1,300 and 1,600 individuals by 2026.
“I am proud that Siemens has chosen to grow its laboratory diagnostics unit in Massachusetts. The Commonwealth is pleased to continue building a pro-growth economic environment that creates more jobs for our communities, and remains focused on supporting globally competitive life sciences and advanced manufacturing. I thank Siemens Healthineers for their commitment to Massachusetts, and look forward to continuing to partner with the company to move this important economic development project forward,” Mass. Governor Charlie Baker said in a prepared statement.
Earlier this month, Siemens Healthineers said it inked a 4-year research deal with N.Y. state healthcare provider Northwell Health.
The 2 parties aim to develop research projects evaluating clinical effectiveness and outcomes using data analytics-based population health evidence. As part of the 4-year partnership deal, Siemens Healthineers will also provide full-time employees who will work jointly with Northwell Health.
The post Siemens invests $300m in Walpole, Mass facility appeared first on MassDevice.